UiPath Inc. (NYSE:PATH – Get Free Report) has earned a consensus rating of “Hold” from the eighteen analysts that are currently covering the firm, Marketbeat reports. Sixteen research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year target price among brokerages that have covered the stock in the last year is $17.71.
Several brokerages recently weighed in on PATH. Bank of America lifted their price objective on UiPath from $16.00 to $18.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Needham & Company LLC reissued a “hold” rating on shares of UiPath in a research report on Friday, September 6th. DA Davidson raised their price objective on shares of UiPath from $13.00 to $15.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Morgan Stanley reissued an “equal weight” rating and set a $15.00 target price on shares of UiPath in a report on Friday, September 6th. Finally, Wells Fargo & Company raised their price target on UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a report on Friday, September 6th.
View Our Latest Stock Analysis on UiPath
Insiders Place Their Bets
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of PATH. PNC Financial Services Group Inc. grew its holdings in shares of UiPath by 50.1% during the 4th quarter. PNC Financial Services Group Inc. now owns 19,135 shares of the healthcare company’s stock valued at $475,000 after purchasing an additional 6,385 shares during the last quarter. Corient Private Wealth LLC grew its stake in shares of UiPath by 8.7% during the fourth quarter. Corient Private Wealth LLC now owns 34,480 shares of the healthcare company’s stock valued at $856,000 after buying an additional 2,756 shares during the last quarter. Hsbc Holdings PLC increased its holdings in shares of UiPath by 14.8% in the fourth quarter. Hsbc Holdings PLC now owns 98,725 shares of the healthcare company’s stock worth $2,455,000 after buying an additional 12,691 shares during the period. Treasurer of the State of North Carolina lifted its stake in shares of UiPath by 2.3% in the 4th quarter. Treasurer of the State of North Carolina now owns 168,768 shares of the healthcare company’s stock valued at $4,192,000 after acquiring an additional 3,780 shares during the last quarter. Finally, California State Teachers Retirement System boosted its holdings in UiPath by 5.3% during the 4th quarter. California State Teachers Retirement System now owns 565,216 shares of the healthcare company’s stock valued at $14,040,000 after acquiring an additional 28,435 shares during the period. 62.50% of the stock is currently owned by institutional investors.
UiPath Stock Up 4.5 %
PATH opened at $12.49 on Tuesday. UiPath has a twelve month low of $10.37 and a twelve month high of $27.87. The company’s 50-day moving average price is $12.18 and its two-hundred day moving average price is $15.17. The stock has a market cap of $7.15 billion, a price-to-earnings ratio of -78.06 and a beta of 0.88.
UiPath (NYSE:PATH – Get Free Report) last posted its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, beating the consensus estimate of $0.03 by $0.01. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The business had revenue of $316.00 million for the quarter, compared to the consensus estimate of $303.69 million. During the same quarter in the prior year, the business earned ($0.09) earnings per share. UiPath’s revenue for the quarter was up 10.0% on a year-over-year basis. As a group, sell-side analysts anticipate that UiPath will post -0.23 earnings per share for the current year.
About UiPath
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Further Reading
- Five stocks we like better than UiPath
- 3 Warren Buffett Stocks to Buy Now
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- The How and Why of Investing in Gold Stocks
- MarketBeat Week in Review – 9/30 – 10/4
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Top Streaming Companies: Who’s Winning the Battle?
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.